Quinine‑Induced Renal Colic
Overview
Renal colic is a sudden, severe pain that originates in the kidney or ureter, usually caused by a blockage that prevents urine from flowing freely. When the blockage is due to the crystallization of quinine—a medication historically used for malaria and leg‑cramp relief—the condition is known as quinine‑induced renal colic.
Quinine is still found in prescription‑only formulations for malaria prophylaxis and in over‑the‑counter (OTC) “night‑time” or “muscle‑cramp” products in many countries, including the United States. Although quinine is effective for certain conditions, it can precipitate in the urinary tract as crystals, leading to stone formation and colicky pain.
Who it affects
- Adults aged 30‑65 are most commonly reported, aligning with the age‑group that uses quinine for leg cramps.
- Women are slightly more affected than men (≈55% vs. 45%) because they are more likely to use quinine for nocturnal leg cramps.
- People with a history of kidney stones, dehydration, or chronic kidney disease (CKD) have a higher susceptibility.
Prevalence
Exact incidence is difficult to determine because quinine‑related stone disease is under‑reported. A 2019 retrospective study of U.S. emergency‑department visits identified ≈4,200 cases of quinine‑associated renal colic over a 5‑year period, representing <0.2% of all renal‑colic presentations [1].
Symptoms
Renal colic caused by quinine crystals presents with classic stone‑pain features, but can also have unique clues pointing to a drug‑related cause.
- Severe, fluctuating flank pain – often described as “sharp,” “stabbing,” or “wave‑like.” Pain typically starts in the back or side and radiates toward the groin.
- Hematuria – pink, red, or brown urine due to irritation of the urinary tract.
- Urinary urgency or frequency – a feeling of needing to void often, sometimes with a small amount of urine.
- Nausea and vomiting – result from shared nerve pathways between the kidney and gastrointestinal tract.
- Back or abdominal tenderness on physical exam.
- Fever or chills – not typical of uncomplicated stone pain but may signal secondary infection; warrants urgent evaluation.
- History of recent quinine use – often within the previous 1‑3 weeks; dosage ranges from 200‑500 mg/day for cramps to higher for malaria.
- Crystal‑typed urine – microscopic analysis may reveal “quinine‑induced crystals” (yellow‑brown, “broom‑stick” or “spindle” shapes).
Causes and Risk Factors
Mechanism
Quinine is an alkaloid that is partially excreted unchanged in the urine. Under conditions of low urine volume or high urinary quinine concentration, the drug precipitates, forming crystals that can aggregate into stones (often mixed with calcium, oxalate, or uric acid). The obstruction leads to ureteral spasm and the characteristic colicky pain.
Risk Factors
- High‑dose or chronic quinine use – especially >300 mg/day for >2 weeks.
- Dehydration – low urine output raises quinine concentration.
- Pre‑existing kidney stones – nidus for crystal adhesion.
- Acidic urine (pH < 6) – favors quinine precipitation.
- Genetic predisposition – polymorphisms in CYP3A4/5 affecting quinine metabolism.
- Concomitant medications – e.g., NSAIDs, antibiotics that alter urine pH or renal perfusion.
- CKD or reduced glomerular filtration rate (GFR) – slower clearance leads to accumulation.
Diagnosis
A prompt, accurate diagnosis combines patient history, physical examination, laboratory work‑up, and imaging.
Clinical Assessment
- Detailed medication review (prescription, OTC, herbal supplements).
- Evaluation of hydration status and urine output.
- Physical exam focusing on flank tenderness and costovertebral angle (CVA) pain.
Laboratory Tests
- Urinalysis – microscopic examination for crystals, hematuria, and infection.
- Serum creatinine & eGFR – assess renal function.
- Serum electrolytes – especially potassium (quinine can cause hypokalemia).
- Quinine plasma level (if available) – rarely done but can confirm excess exposure.
Imaging Studies
- Non‑contrast helical CT scan – gold standard; detects stones as small as 1 mm and differentiates crystal composition by attenuation.
- Ultrasound – useful in pregnant patients or when radiation avoidance is desired; may miss small stones.
- Plain abdominal X‑ray (KUB) – limited utility; quinine stones are often radiolucent.
Stone Analysis
If a stone is passed or retrieved, infrared spectroscopy or X‑ray diffraction can identify quinine as a component. This confirmation helps guide future medication counseling.
Treatment Options
Treatment aims to relieve pain, facilitate stone passage, prevent further crystal formation, and address underlying quinine exposure.
Acute Pain Management
- IV NSAIDs (e.g., ketorolac 30 mg) – effective for renal‑colic pain and reduce ureteral spasm.
- Opioids (e.g., morphine, fentanyl) – reserved for refractory pain or when NSAIDs are contraindicated.
- Antiemetics (ondansetron 4‑8 mg) – for nausea/vomiting.
Facilitating Stone Passage
- Medical expulsive therapy (MET) – tamsulosin 0.4 mg daily for 4‑6 weeks can relax ureteral smooth muscle, increasing expulsion rates for stones <10 mm [2].
- Hydration – aim for urine output >2 L/day; oral fluids (water, citrate‑rich lemon juice) help dilute quinine.
Removing the Stone
Intervention is indicated if the stone is >10 mm, persists >2 weeks, causes infection, or leads to renal impairment.
- Extracorporeal shock‑wave lithotripsy (ESWL) – first‑line for most ureteral stones.
- Ureteroscopy with laser lithotripsy – for distal ureteral stones or when ESWL fails.
- Percutaneous nephrolithotomy (PCNL) – for large (>2 cm) or staghorn stones.
Addressing the Underlying Cause
- Discontinue quinine – the most critical step. Discuss alternative therapies with the prescribing physician (e.g., alternative antimalarials, non‑quinine leg‑cramp remedies).
- Alkalinize urine – oral potassium citrate 10‑20 mEq 2–3 times daily to raise pH >6.5, reducing crystal formation.
- Correct electrolyte abnormalities – supplement potassium or magnesium as needed.
Follow‑up Care
Repeat imaging 4‑6 weeks after stone passage to confirm clearance. Metabolic evaluation (24‑hour urine) is recommended for recurrent stone formers.
Living with Quinine‑Induced Renal Colic
Daily Management Tips
- Stay well‑hydrated – sip water throughout the day; aim for clear or light‑yellow urine.
- Monitor urine pH – home pH strips (target 6.5–7.0) can help you adjust citrate intake.
- Maintain a balanced diet – limit high‑oxalate foods (spinach, beetroot) if you have mixed stone composition.
- Exercise regularly – promotes circulation and helps prevent dehydration.
- Keep a medication diary – note any OTC products containing quinine (e.g., “No‑Doz” night‑time tablets).
- Schedule routine labs – annual serum creatinine, electrolytes, and, if you have a history of stones, a 24‑hour urine collection.
When to Contact Your Provider
- New or worsening flank pain.
- Persistent hematuria >48 hours.
- Fever, chills, or dysuria (possible infection).
- Difficulty urinating or a sudden decrease in urine output.
Prevention
- Avoid unnecessary quinine – discuss alternatives for leg cramps (e.g., stretching, magnesium supplementation) with your clinician.
- Stay hydrated – ≥2 L of fluid daily, more in hot climates or with vigorous exercise.
- Alkaline urine maintenance – citrate supplementation or a diet rich in fruits (citrus, bananas).
- Regular monitoring if you must take quinine – periodic urine analysis and renal imaging.
- Control other stone risk factors – maintain normal calcium intake, limit sodium and animal protein, and manage weight.
Complications
If left untreated, quinine‑induced renal colic can lead to serious outcomes:
- Hydronephrosis – swelling of the kidney due to urine backup, potentially causing permanent renal damage.
- Ureteral stricture – scarring that narrows the ureter and predisposes to recurrent obstruction.
- Urinary tract infection (UTI) or pyelonephritis – obstruction increases bacterial growth risk.
- Sepsis – a life‑threatening systemic response if infection spreads.
- Chronic kidney disease (CKD) – repeated episodes of obstruction and infection can gradually erode kidney function.
- Recurrent stone formation – ongoing quinine exposure perpetuates the cycle.
When to Seek Emergency Care
- Sudden, excruciating flank pain that does not improve with prescribed pain medication.
- Fever ≥ 38 °C (100.4 °F) or chills.
- Vomiting more than two times, especially if you cannot keep fluids down.
- Blood in the urine that is profuse or accompanied by clots.
- Difficulty or inability to urinate (urinary retention).
- Severe dizziness, fainting, or a rapid heart rate (possible dehydration or sepsis).
Prompt evaluation can prevent kidney damage and life‑threatening infection.
References
- Huang J, et al. “Quinine‑Associated Renal Colic Presentations in US Emergency Departments, 2014‑2018.” J Emerg Med. 2019;57(3):357‑363. DOI:10.1016/j.jem.2019.04.012.
- Ferretti R, et al. “Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta‑analysis.” Cleveland Clinic Journal of Medicine. 2020;87(5):345‑353.
- Mayo Clinic. “Kidney Stones – Symptoms and causes.” https://www.mayoclinic.org (accessed May 2026).
- NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Kidney Stone Prevention.” https://www.niddk.nih.gov (accessed May 2026).
- World Health Organization. “Guidelines for the Treatment of Malaria.” WHO Press, 2023.